Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multi-Center Open-label Investigation to Assess the Pharmacokinetics, Safety and Tolerability of DM199 in Patients With Diabetes Mellitus and Chronic Kidney Disease

Next Previous
Search
Trial Profile

A Multi-Center Open-label Investigation to Assess the Pharmacokinetics, Safety and Tolerability of DM199 in Patients With Diabetes Mellitus and Chronic Kidney Disease

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 04 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Rinvecalinase alfa (Primary)
  • Indications Diabetic nephropathies; Renal failure
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors DiaMedica Therapeutics

    • Most Recent Events

    • 25 Feb 2021 According to a DiaMedica Therapeutics media release, Dr. Harry Alcorn (Chief Medical Officer) will be presenting CKD DM199 Research Update at the 3rd Chronic Kidney Disease Drug Development (CKD3) summit virtually on 2nd Mar 2021.The presentation will include data from this CKD Phase 1b study (NCT03795389) and an overview of the CKD Phase II Redux study design.
    • 26 Mar 2020 According to a DiaMedica Therapeutics media release, the company will be presenting a poster at the National Kidney Foundation (NKF) 2020 Spring Clinical Meetings Live Virtual Conference
    • 13 Nov 2019 According to a DiaMedica Therapeutics media release, the company intends to release full study results at an upcoming conference, including a breakout analysis of moderate and severe patients and results by dose level.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top